MedTrace Logo

Carpal Tunnel Syndrome and Amyloid Cardiomyopathy

NCT02792790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2021-12-22

No results posted yet for this study

Summary

The investigators will prospectively evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid in the soft tissue that is removed. Patients who have tissue that stains positive for amyloid will undergo cardiac testing to look for evidence of cardiac involvement.

Conditions

  • Amyloidosis
  • Cardiomyopathy
  • Transthyretin Amyloidosis
  • Senile Systemic Amyloidosis
  • Carpal Tunnel Syndrome

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Mazen Hanna, MD · The Cleveland Clinic

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2021-07-21
Completion
2021-12-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792790 on ClinicalTrials.gov